AKBA - Akebia Therapeutics, Inc.
IEX Last Trade
1.955
0.015 0.767%
Share volume: 67,767
Last Updated: Fri 27 Dec 2024 08:29:43 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.94
0.02
0.77%
Summary score
26%
Profitability
25%
Dept financing
25%
Liquidity
21%
Performance
28%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-45.8%
Return on assets
-7.1%
Return on sales
-70.61%
Return on invested capital
81.05%
Total debt ratio
87.55%
Debt ratio change over timeo
-37.88%
Current Ratio
1.6%
Quick Ratio
1.34%
Cash Position Ratio
0.91%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
36.14%
Return on assets
-3.84%
Return on sales
-22.77%
Return on invested capital
-24.22%
Total debt ratio
113.02%
Debt ratio change over timeo
-144.33%
Current Ratio
1.39%
Quick Ratio
1.14%
Cash Position Ratio
0.56%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
65.98%
Return on assets
-6.6%
Return on sales
-45.63%
Return on invested capital
-39.06%
Total debt ratio
112.09%
Debt ratio change over time
-565.83%
Current Ratio
1.7%
Quick Ratio
1.31%
Cash Position Ratio
0.63%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-2070.26%
Return on assets
120.29%
Return on sales
1446.85%
Return on invested capital
1401.03%
Total debt ratio
-3787.51%
Debt ratio change over time
-37.88%
Current Ratio
-57.29%
Quick Ratio
-44.72%
Cash Position Ratio
-22.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AKBA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -45.8% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.1% | 2.76% | 3.15% | 5.62% |
| Return on sales | -70.61% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 81.05% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 61% | 61% |
| Total debt ratio | 87.55% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -37.88% | 308.97% | -6.99% | 1.18% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 1.39% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.14% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 29% | 14% | 33% | 75% |
| Short-term ratios | AKBA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 36.14% | 13.77% | 13.25% | 3.8% |
| Return on assets | -3.84% | 2.43% | 1.89% | 3.09% |
| Return on sales | -22.77% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -24.22% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 55% | 53% | 78% |
| Total debt ratio | 113.02% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -144.33% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 45% | 21% | 6% |
| Current Ratio | 1.39% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.14% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.56% | 0.36% | 1.28% | 2.93% |
| Liquididy | 17% | 12% | 31% | 75% |